Prior to the introduction of PCV, adults with HIV in a rural area of Kenya were nearly five times more likely to have pneumococcal pneumonia than non-infected adults, and the majority of cases with bacteremia (blood infection) occurred in HIV positive individuals.
Full Citation:
Bigogo GM, Audi A, Auko J et al.. 2019. Indirect effects of 10-Valent pneumococcal conjugate vaccine against adult pneumococcal pneumonia in rural western Kenya. Clinical Infectious Diseases. 69(12).
Title of Article: Indirect effects of 10-Valent pneumococcal conjugate vaccine against adult pneumococcal pneumonia in rural western Kenya
Author(s): Bigogo GM, Audi A, Auko J et al.
Publication Year: 2019
Publication Name: Clinical Infectious Diseases
Publication Volume: 69(12)
Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/30785189
DOI (Digital Object Identifier): 10.1093/cid/ciz139
Topics: Health
Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia
Immunization Terms: Herd effects | HIV
Countries: Kenya
WHO Regions: Africa